Log in or Sign up for Free to view tailored content for your specialty!
Pediatric ID News
Short antibiotic course holds up against extended course for pediatric pneumonia
An extended course of antibiotics showed no short-term clinical benefit for children hospitalized with community-acquired pneumonia compared with a standard, shorter course, a study found.
Moderna’s COVID-19 vaccine safe, effective in children aged 6 to 11 years
Moderna’s COVID-19 vaccine was found to be safe and effective among children aged 6 to 11 years, according to interim phase 2/3 findings from the KidCOVE trial published in The New England Journal of Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: Understanding pediatric hepatitis cases linked to adenovirus
With the CDC suggesting that adenovirus should be considered in diagnosis of acute hepatitis in children, amidst a possible outbreak of cases in Europe and the U.S., some pediatricians are wondering what to look out for in their own practices.
Antibody titers higher in moms infected with SARS-CoV-2 then boosted during pregnancy
Women with COVID-19 during pregnancy who subsequently received one mRNA vaccine dose had the highest levels of antibodies at delivery compared with infected, unvaccinated women and vaccinated women who were never infected.
VIDEO: Physicians ‘very surprised’ by emergence of SARS-CoV-2 variants
CHICAGO — Although questions remain regarding SARS-CoV-2, including the number of boosters a person will eventually require and how to manage patients with long COVID, physicians have learned a lot about the virus.
Moms who receive investigational RSV vaccine pass antibodies to infants
Infants born to mothers who were immunized with an investigational vaccine against respiratory syncytial virus — or RSV — received antibodies across the placenta, with no “evident safety concerns,” results from a phase 2b trial showed.
Data show most pregnant women with COVID-19 pass antibodies to neonates
LISBON, Portugal — Pregnant women with SARS-CoV-2 infection passed antibodies to newborns in most cases, although there were no cases of neonatal infection in a study presented here.
FDA approves first treatment for young children with COVID-19
The FDA has approved Veklury for pediatric patients aged 28 days and older who are hospitalized for COVID-19 or have mild to moderate COVID-19 and are at risk for severe disease.
COVID-19 third leading cause of death in US
COVID-19 was the third leading cause of death in 2021, while the differences in death rates between certain racial and ethnic minority groups remain, the CDC announced in a press release.
VIDEO: Considerations for organizing COVID-19 vaccination clinics
In this video, Andrew Pinto, MD, CCFP, FRCPC, MSc, discusses best practices for planning and implementing successful COVID-19 vaccination clinics in Canada and the United States.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read